The editors of the International Journal of Gynecology and Obstetrics (IJGO) are pleased to announce the winner of the prize award for the best clinical research paper from a low-or middle-income country published in the IJGO during 2012. The winning paper is by A Adanikin, E Orji, O Fasubaa, U Onwudiegwu, O Ijarotimi, O Olaniyan. The effect of post-cesarean rectal misoprostol on intestinal motility. Int J Gynecol Obstet 2012; 119(2): 159-162. It was published in the November 2012 issue of the IJGO.
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All clinical research articles submitted to the IJGO from low-and middle-income countries that were published in 2012 were considered for this prize. The paper was chosen from 94 qualifying articles. Selection and review were undertaken by the editors and the decision was endorsed by the Editorial Board of the IJGO.
Additional papers that are worthy of special recognition are awarded an honorable mention. While the honorable mention recognition does not include a financial award, each author receives a certificate of recognition and a letter of commendation from the editors of the IJGO.
The IJGO Prize Paper Award was established in 1998 for the purpose of encouraging investigators, especially young scientists, from low-and middle-income countries to submit their best clinical research articles for publication in the Journal. The IJGO is the official publication of the International Federation of Gynecology and Obstetrics (FIGO), the primary international organization for the specialty of obstetrics and International Journal of Gynecology and Obstetrics 121 (2013) 197-198 International Journal of Gynecology and Obstetrics 119 (2012) 
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Objective: To determine whether rectally administered misoprostol can induce intestinal motility compared with oxytocin infusion when used to prevent primary postpartum hemorrhage after cesarean delivery. Methods: In a prospective randomized double-blind study in Nigeria, 218 parturients undergoing cesarean delivery who had risk factors for primary postpartum hemorrhage were enrolled between July 1, 2010, and March 31, 2011. Participants received 600 μg of rectal misoprostol or 20 intravenous units of oxytocin for 4 hours after surgery. The primary outcome was time until passage of flatus. Adverse effects, need for additional analgesic, and length of hospital stay were also assessed. Results: The misoprostol group had a significantly shorter mean postoperative interval to passage of flatus (20.27± 7.77 hours versus 38.34 ±10.98 hours; P b 0.001) and commencement of regular diet (21.08± 7.69 hours versus 39.13±10.94 hours; P b 0.001). Gastrointestinal adverse effects were more frequent, albeit not significantly, in the misoprostol group: nausea, 6.4% versus 1.8%; vomiting, 7.3% versus 2.8%; and abdominal distension, 3.7% versus 2.8%. The need for additional analgesic was the same in the 2 groups. Conclusion: After cesarean delivery, rectal misoprostol had the added benefit of inducing intestinal motility. 
